TD Cowen analyst John Blackledge maintained a Buy rating on IAC/InteractiveCorp. (IAC – Research Report) today and set a price target of ...
Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...
TD Cowen was established in 1918 as a bond trading firm and quickly expanded into clearing and execution services. By the 1970s, it had carved a niche in railroad bonds and grown a solid research ...
Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...
Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product ...
TD Cowen analyst Jason Gabelman maintained a Hold rating on TotalEnergies (TTE – Research Report) today. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback